Cellular uptake of phosphorothioate oligonucleotide facilitated by cationic porphyrin: a microfluorescence study

Biopolymers
Eva KocisováPierre-Yves Turpin

Abstract

Cationic 5,10,15,20-tetrakis (1-methyl-4-pyridyl) porphyrin was tested as a delivery agent for oligonucleotides. By using fluorescence microimaging, it has been shown that complexation of the porphyrin to the phosphorothioate analog of dT(15) labeled by rhodamine enabled its nonendocytic penetration into the cell and regular distribution in the cytoplasm and preferentially into the nucleus. Time-resolved microfluorescence spectroscopy revealed that the oligonucleotide integrity was kept. A small fraction of the porphyrin molecules seems to undergo change of the binding mode after internalization, probably due to duplex formation between the oligonucleotide and its cellular target sequences, or due to dissociation of the porphyrin from the oligonucleotide and subsequent interactions in the cellular environment.

References

Nov 25, 1998·Nucleic Acids Research·L BenimetskayaC A Stein
May 16, 2003·Journal of Medicinal Chemistry·Jarmila KrálováVladimír Král
Apr 15, 2004·Drug Discovery Today·Peter Järver, Ulo Langel
Aug 7, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Dirk LochmannAndreas Zimmer
Nov 30, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jörg WeyermannAndreas Zimmer

❮ Previous
Next ❯

Citations

Oct 2, 2012·Biochimica Et Biophysica Acta·Armin W OpitzNorman J Wagner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.